Loading…

Extracellular Vesicles and DAMPs in Cancer: A Mini-Review

Certain cancer therapy has been shown to induce immunogenic cell death in cancer cells and may promote tumor progression instead. The external stress or stimuli may induce cell death and contribute toward the secretion of pro inflammatory molecules. The release of damage-associated molecular pattern...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology 2021-10, Vol.12, p.740548-740548
Main Authors: Abu, Nadiah, Rus Bakarurraini, Nurul Ainaa Adilah, Nasir, Siti Nurmi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c465t-74fcefcc856fb9c4e3d6c8b79a196801c9ea7046eea6ed64c26f7ff6dbad74723
cites cdi_FETCH-LOGICAL-c465t-74fcefcc856fb9c4e3d6c8b79a196801c9ea7046eea6ed64c26f7ff6dbad74723
container_end_page 740548
container_issue
container_start_page 740548
container_title Frontiers in immunology
container_volume 12
creator Abu, Nadiah
Rus Bakarurraini, Nurul Ainaa Adilah
Nasir, Siti Nurmi
description Certain cancer therapy has been shown to induce immunogenic cell death in cancer cells and may promote tumor progression instead. The external stress or stimuli may induce cell death and contribute toward the secretion of pro inflammatory molecules. The release of damage-associated molecular patterns (DAMPs) upon induction of therapy or cell death has been shown to induce an inflammatory response. Nevertheless, the mechanism as to how the DAMPs are released and engage in such activity needs further in-depth investigation. Interestingly, some studies have shown that DAMPs can be released through extracellular vesicles (EVs) and can bind to receptors such as toll-like receptors (TCRs). Ample pre-clinical studies have shown that cancer-derived EVs are able to modulate immune responses within the tumor microenvironment. However, the information on the presence of such DAMPs within EVs is still elusive. Therefore, this mini-review attempts to summarize and appraise studies that have shown the presence of DAMPs within cancer-EVs and how it affects the downstream cellular process.
doi_str_mv 10.3389/fimmu.2021.740548
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_36541cb2ea16476a9ed58b7471759533</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_36541cb2ea16476a9ed58b7471759533</doaj_id><sourcerecordid>2591228973</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-74fcefcc856fb9c4e3d6c8b79a196801c9ea7046eea6ed64c26f7ff6dbad74723</originalsourceid><addsrcrecordid>eNpVkUtLxDAUhYMoKqM_wI106aZj3mlcCMP4BEURdRvS9EYjfWgy9fHvbR0VzSbhJvc75-YgtEPwlLFC7_vQNP2UYkqmimPBixW0SaTkOaOUr_45b6DtlJ7wsLhmjIl1tMG4ooRjtYn08fsiWgd13dc2ZveQgqshZbatsqPZ5XXKQpvNbesgHmSz7DK0Ib-B1wBvW2jN2zrB9vc-QXcnx7fzs_zi6vR8PrvIHZdikSvuHXjnCiF9qR0HVklXlEpbomWBidNgFeYSwEqoJHdUeuW9rEpbqcEmm6DzJbfq7JN5jqGx8cN0NpivQhcfjI2L0bVhUnDiSgqWSK6k1VCJQYorooQWw-wTdLhkPfdlA5WDdhi-_gf9f9OGR_PQvZpCCM6wHAB734DYvfSQFqYJafw920LXJ0OFJpQWWo1aZPnUxS6lCP5XhmAzJmi-EjRjgmaZ4NCz-9ffb8dPXuwTg7aXDA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2591228973</pqid></control><display><type>article</type><title>Extracellular Vesicles and DAMPs in Cancer: A Mini-Review</title><source>Open Access: PubMed Central</source><creator>Abu, Nadiah ; Rus Bakarurraini, Nurul Ainaa Adilah ; Nasir, Siti Nurmi</creator><creatorcontrib>Abu, Nadiah ; Rus Bakarurraini, Nurul Ainaa Adilah ; Nasir, Siti Nurmi</creatorcontrib><description>Certain cancer therapy has been shown to induce immunogenic cell death in cancer cells and may promote tumor progression instead. The external stress or stimuli may induce cell death and contribute toward the secretion of pro inflammatory molecules. The release of damage-associated molecular patterns (DAMPs) upon induction of therapy or cell death has been shown to induce an inflammatory response. Nevertheless, the mechanism as to how the DAMPs are released and engage in such activity needs further in-depth investigation. Interestingly, some studies have shown that DAMPs can be released through extracellular vesicles (EVs) and can bind to receptors such as toll-like receptors (TCRs). Ample pre-clinical studies have shown that cancer-derived EVs are able to modulate immune responses within the tumor microenvironment. However, the information on the presence of such DAMPs within EVs is still elusive. Therefore, this mini-review attempts to summarize and appraise studies that have shown the presence of DAMPs within cancer-EVs and how it affects the downstream cellular process.</description><identifier>ISSN: 1664-3224</identifier><identifier>EISSN: 1664-3224</identifier><identifier>DOI: 10.3389/fimmu.2021.740548</identifier><identifier>PMID: 34721407</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>Alarmins - immunology ; Animals ; cancer ; Carcinogenesis ; exosome ; Extracellular Vesicles - metabolism ; Humans ; Immunity ; Immunology ; Immunomodulation ; Neoplasms - immunology ; Neoplasms - therapy ; PRR ; TLR ; Toll-Like Receptors - metabolism ; Tumor Microenvironment</subject><ispartof>Frontiers in immunology, 2021-10, Vol.12, p.740548-740548</ispartof><rights>Copyright © 2021 Abu, Rus Bakarurraini and Nasir.</rights><rights>Copyright © 2021 Abu, Rus Bakarurraini and Nasir 2021 Abu, Rus Bakarurraini and Nasir</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-74fcefcc856fb9c4e3d6c8b79a196801c9ea7046eea6ed64c26f7ff6dbad74723</citedby><cites>FETCH-LOGICAL-c465t-74fcefcc856fb9c4e3d6c8b79a196801c9ea7046eea6ed64c26f7ff6dbad74723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554306/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554306/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34721407$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abu, Nadiah</creatorcontrib><creatorcontrib>Rus Bakarurraini, Nurul Ainaa Adilah</creatorcontrib><creatorcontrib>Nasir, Siti Nurmi</creatorcontrib><title>Extracellular Vesicles and DAMPs in Cancer: A Mini-Review</title><title>Frontiers in immunology</title><addtitle>Front Immunol</addtitle><description>Certain cancer therapy has been shown to induce immunogenic cell death in cancer cells and may promote tumor progression instead. The external stress or stimuli may induce cell death and contribute toward the secretion of pro inflammatory molecules. The release of damage-associated molecular patterns (DAMPs) upon induction of therapy or cell death has been shown to induce an inflammatory response. Nevertheless, the mechanism as to how the DAMPs are released and engage in such activity needs further in-depth investigation. Interestingly, some studies have shown that DAMPs can be released through extracellular vesicles (EVs) and can bind to receptors such as toll-like receptors (TCRs). Ample pre-clinical studies have shown that cancer-derived EVs are able to modulate immune responses within the tumor microenvironment. However, the information on the presence of such DAMPs within EVs is still elusive. Therefore, this mini-review attempts to summarize and appraise studies that have shown the presence of DAMPs within cancer-EVs and how it affects the downstream cellular process.</description><subject>Alarmins - immunology</subject><subject>Animals</subject><subject>cancer</subject><subject>Carcinogenesis</subject><subject>exosome</subject><subject>Extracellular Vesicles - metabolism</subject><subject>Humans</subject><subject>Immunity</subject><subject>Immunology</subject><subject>Immunomodulation</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - therapy</subject><subject>PRR</subject><subject>TLR</subject><subject>Toll-Like Receptors - metabolism</subject><subject>Tumor Microenvironment</subject><issn>1664-3224</issn><issn>1664-3224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkUtLxDAUhYMoKqM_wI106aZj3mlcCMP4BEURdRvS9EYjfWgy9fHvbR0VzSbhJvc75-YgtEPwlLFC7_vQNP2UYkqmimPBixW0SaTkOaOUr_45b6DtlJ7wsLhmjIl1tMG4ooRjtYn08fsiWgd13dc2ZveQgqshZbatsqPZ5XXKQpvNbesgHmSz7DK0Ib-B1wBvW2jN2zrB9vc-QXcnx7fzs_zi6vR8PrvIHZdikSvuHXjnCiF9qR0HVklXlEpbomWBidNgFeYSwEqoJHdUeuW9rEpbqcEmm6DzJbfq7JN5jqGx8cN0NpivQhcfjI2L0bVhUnDiSgqWSK6k1VCJQYorooQWw-wTdLhkPfdlA5WDdhi-_gf9f9OGR_PQvZpCCM6wHAB734DYvfSQFqYJafw920LXJ0OFJpQWWo1aZPnUxS6lCP5XhmAzJmi-EjRjgmaZ4NCz-9ffb8dPXuwTg7aXDA</recordid><startdate>20211015</startdate><enddate>20211015</enddate><creator>Abu, Nadiah</creator><creator>Rus Bakarurraini, Nurul Ainaa Adilah</creator><creator>Nasir, Siti Nurmi</creator><general>Frontiers Media S.A</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20211015</creationdate><title>Extracellular Vesicles and DAMPs in Cancer: A Mini-Review</title><author>Abu, Nadiah ; Rus Bakarurraini, Nurul Ainaa Adilah ; Nasir, Siti Nurmi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-74fcefcc856fb9c4e3d6c8b79a196801c9ea7046eea6ed64c26f7ff6dbad74723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Alarmins - immunology</topic><topic>Animals</topic><topic>cancer</topic><topic>Carcinogenesis</topic><topic>exosome</topic><topic>Extracellular Vesicles - metabolism</topic><topic>Humans</topic><topic>Immunity</topic><topic>Immunology</topic><topic>Immunomodulation</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - therapy</topic><topic>PRR</topic><topic>TLR</topic><topic>Toll-Like Receptors - metabolism</topic><topic>Tumor Microenvironment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abu, Nadiah</creatorcontrib><creatorcontrib>Rus Bakarurraini, Nurul Ainaa Adilah</creatorcontrib><creatorcontrib>Nasir, Siti Nurmi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abu, Nadiah</au><au>Rus Bakarurraini, Nurul Ainaa Adilah</au><au>Nasir, Siti Nurmi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extracellular Vesicles and DAMPs in Cancer: A Mini-Review</atitle><jtitle>Frontiers in immunology</jtitle><addtitle>Front Immunol</addtitle><date>2021-10-15</date><risdate>2021</risdate><volume>12</volume><spage>740548</spage><epage>740548</epage><pages>740548-740548</pages><issn>1664-3224</issn><eissn>1664-3224</eissn><abstract>Certain cancer therapy has been shown to induce immunogenic cell death in cancer cells and may promote tumor progression instead. The external stress or stimuli may induce cell death and contribute toward the secretion of pro inflammatory molecules. The release of damage-associated molecular patterns (DAMPs) upon induction of therapy or cell death has been shown to induce an inflammatory response. Nevertheless, the mechanism as to how the DAMPs are released and engage in such activity needs further in-depth investigation. Interestingly, some studies have shown that DAMPs can be released through extracellular vesicles (EVs) and can bind to receptors such as toll-like receptors (TCRs). Ample pre-clinical studies have shown that cancer-derived EVs are able to modulate immune responses within the tumor microenvironment. However, the information on the presence of such DAMPs within EVs is still elusive. Therefore, this mini-review attempts to summarize and appraise studies that have shown the presence of DAMPs within cancer-EVs and how it affects the downstream cellular process.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>34721407</pmid><doi>10.3389/fimmu.2021.740548</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-3224
ispartof Frontiers in immunology, 2021-10, Vol.12, p.740548-740548
issn 1664-3224
1664-3224
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_36541cb2ea16476a9ed58b7471759533
source Open Access: PubMed Central
subjects Alarmins - immunology
Animals
cancer
Carcinogenesis
exosome
Extracellular Vesicles - metabolism
Humans
Immunity
Immunology
Immunomodulation
Neoplasms - immunology
Neoplasms - therapy
PRR
TLR
Toll-Like Receptors - metabolism
Tumor Microenvironment
title Extracellular Vesicles and DAMPs in Cancer: A Mini-Review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T10%3A44%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extracellular%20Vesicles%20and%20DAMPs%20in%20Cancer:%20A%20Mini-Review&rft.jtitle=Frontiers%20in%20immunology&rft.au=Abu,%20Nadiah&rft.date=2021-10-15&rft.volume=12&rft.spage=740548&rft.epage=740548&rft.pages=740548-740548&rft.issn=1664-3224&rft.eissn=1664-3224&rft_id=info:doi/10.3389/fimmu.2021.740548&rft_dat=%3Cproquest_doaj_%3E2591228973%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c465t-74fcefcc856fb9c4e3d6c8b79a196801c9ea7046eea6ed64c26f7ff6dbad74723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2591228973&rft_id=info:pmid/34721407&rfr_iscdi=true